Brief: Kazia Therapeutics Posts HY Loss After Income Tax Benefit Attributable A$13.6 Million
28/02/2023 03:54
Feb 28 (Reuters) - Kazia Therapeutics Ltd KZA.AX :
* HY LOSS AFTER INCOME TAX BENEFIT ATTRIBUTABLE A$13.6
MILLION
VERSUS LOSS A$13.2 MILLION
Source text for Eikon: ID:nASX8XkthD
Further company coverage: KZA.AX
((reuters.briefs@thomsonreuters.com;))
Recent news on Kazia Therapeutics
See all newsBrief: Kazia Therapeutics Files For Mixed Shelf Of Up To $100 Million – SEC Filing
Brief: Kazia Announces Voluntary Delisting From ASX
Australia's Kazia Therapeutics slumps to 1-yr low on delisting announcement
Brief: Kazia Therapeutics Announces Intention To Voluntarily De-List From ASX
Brief: Kazia Therapeutics Seeks Trading Halt